INDRAMEDCO — Indraprastha Medical Share Price
0.000.00%
Last trade - 00:00- IN₹39.03bn
- IN₹36.18bn
- IN₹12.45bn
- 95
- 20
- 86
- 79
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 21.18 | ||
| PEG Ratio (f) | 1.7 | ||
| EPS Growth (f) | 14.2% | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 7.44 | ||
| Price to Tang. Book | 7.45 | ||
| Price to Free Cashflow | 36.16 | ||
| Price to Sales | 2.92 | ||
| EV to EBITDA | 15.64 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 31.13% | ||
| Return on Equity | 32.19% | ||
| Operating Margin | 14.04% | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | 8,307.68 | 6,133.82 | 8,881.6 | 10,986.7 | 12,447 | 13,478 | 15,152 | 9.57% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +51.92 | -93.9 | +2216.14 | +37.99 | +43.83 | +29.25 | +14.2 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Indraprastha Medical Corporation Limited is an India-based company engaged in the healthcare business. The business activities of the Company are running and operating hospitals, which include Indraprastha Apollo Hospitals and Apollo Hospitals. Indraprastha Apollo Hospitals is a multi-specialty tertiary acute care hospital with approximately 710 beds and is spread over 15 acres and has a built-up area of over 600,000 square feet. It has approximately 52 specialties under one roof with the major specialties being anesthesia, cardiology, cardiac surgery, cancer, pediatrics, critical care, emergency care, fetal medicine, gastroenterology and hepatology, obstetrics & gynecology, interventional radiology, IVF, liver and kidney transplant, nuclear medicine, nephrology, neurosciences, ophthalmology, orthopedics, otolaryngology (ENT), pediatrics, pediatric surgery, psychiatry and clinical psychology, rheumatology, spine surgery, urology and andrology and vascular and endovascular surgery.
Directors
- Jasmine Shah CHM
- Jaideep Gupta CEO (48)
- Prathap Reddy NVC
- C. Tyagi CFO
- Priya Ranjan CCO (49)
- P. Shivakumar MDR
- Vikram Bhat DRC
- Udit Rai DRC
- Sangita Reddy DRC (59)
- Shakti Sinha DRC
- Mahesh Verma DRC
- Renu Karnad NED (69)
- Suneeta Reddy NED (62)
- Vinayak Chatterjee IND
- Arun Rai IND
- Vineeta Rai IND (76)
- Salil Singhal IND (75)
- Deepak Vaidya IND (67)
- Satnam Arora NID (64)
- Madhumita Ganguli NID
- V. Pillai NID
- S. Regunathan NID (67)
- B. Venkataraman NID (88)
- Last Annual
- March 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- March 16th, 1988
- Public Since
- February 24th, 1997
- No. of Shareholders
- 64,631
- No. of Employees
- 2,977
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
- National Stock Exchange of India
- Shares in Issue
- 91,673,000
- Address
- Sarita Vihar,, Delhi-Mathura Road, NEW DELHI, 110076
- Web
- https://delhi.apollohospitals.com/
- Phone
- +91 1129872126
- Auditors
- S.N. Dhawan & Co LLP
Upcoming Events for INDRAMEDCO
Q1 2025 Indraprastha Medical Corporation Ltd Earnings Release
Indraprastha Medical Corporation Ltd Annual Shareholders Meeting
Similar to INDRAMEDCO
Aatmaj Healthcare
National Stock Exchange of India
Apollo Hospitals Enterprise
National Stock Exchange of India
Artemis Medicare Services
National Stock Exchange of India
Aster DM Healthcare
National Stock Exchange of India
Chandan Healthcare
National Stock Exchange of India
FAQ
What is the Indraprastha Medical share price?
As of Today at 21:16 UTC, shares in Indraprastha Medical are trading at IN₹425.70. This share price information is delayed by 15 minutes.
How has the Indraprastha Medical share price performed this year?
Shares in Indraprastha Medical last closed at IN₹425.70 and the price had moved by +82.98% over the past 365 days. In terms of relative price strength the Indraprastha Medical share price has outperformed the S&P BSE 100 Index by +69.53% over the past year.
What are the analyst and broker recommendations for Indraprastha Medical?
The overall consensus recommendation for Indraprastha Medical is Strong Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Indraprastha Medical dividend yield?
The Indraprastha Medical dividend yield is 1.06% based on the trailing twelve month period.
Does Indraprastha Medical pay a dividend?
Last year, Indraprastha Medical paid a total dividend of IN₹4.50, and it currently has a trailing dividend yield of 1.06%. We do not have any data on when Indraprastha Medical is to next pay dividends.
When does Indraprastha Medical next pay dividends?
We do not have data on when Indraprastha Medical is to next pay dividends. The historic dividend yield on Indraprastha Medical shares is currently 1.06%.
How do I buy Indraprastha Medical shares?
To buy shares in Indraprastha Medical you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Indraprastha Medical?
As of the previous close price of IN₹425.70, shares in Indraprastha Medical had a market capitalisation of IN₹39.03bn.
Where are Indraprastha Medical shares listed?
Here are the trading details for Indraprastha Medical:
- Country of listing: India
- Exchange: NSI
- Ticker Symbol: INDRAMEDCO
What kind of share is Indraprastha Medical?
Based on an overall assessment of its quality, value and momentum Indraprastha Medical is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Indraprastha Medical share price forecast for 2025?
The analyst consensus target price for shares in Indraprastha Medical is IN₹670.00. That is 57.39% above the last closing price of IN₹425.70.
Analysts covering Indraprastha Medical currently have a consensus Earnings Per Share (EPS) forecast of IN₹17.60 for the next financial year.
Find out moreWhat is the trend in the Indraprastha Medical share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Indraprastha Medical. Over the past six months, its share price has outperformed the S&P BSE 100 Index by +8.75%.
As of the last closing price of IN₹425.70, shares in Indraprastha Medical were trading +4.82% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Indraprastha Medical PE Ratio?
The Indraprastha Medical PE ratio based on its reported earnings over the past 12 months is 21.18. The shares last closed at IN₹425.70.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Indraprastha Medical?
Indraprastha Medical's management team is headed by:
- Jasmine Shah - CHM
- Jaideep Gupta - CEO
- Prathap Reddy - NVC
- C. Tyagi - CFO
- Priya Ranjan - CCO
- P. Shivakumar - MDR
- Vikram Bhat - DRC
- Udit Rai - DRC
- Sangita Reddy - DRC
- Shakti Sinha - DRC
- Mahesh Verma - DRC
- Renu Karnad - NED
- Suneeta Reddy - NED
- Vinayak Chatterjee - IND
- Arun Rai - IND
- Vineeta Rai - IND
- Salil Singhal - IND
- Deepak Vaidya - IND
- Satnam Arora - NID
- Madhumita Ganguli - NID
- V. Pillai - NID
- S. Regunathan - NID
- B. Venkataraman - NID